Hormone Tracking Startup Eli Raises $1.5 Million USD To Reshape Women's Health

MONTRÉAL, Jan. 21, 2021 /PRNewswire/ - Eli, a company enabling women to own their fertility and health decisions with a novel hormone tracking technology, today announced its $1.5 million USD seed round led by Vectr Ventures. The round closed in December 2020 with the participation of 2048 Ventures, Real Ventures, Techstars, Panache Ventures, Ramen Ventures, MEDTEQ+, and serial entrepreneur Steven Arless, who also joined the board. The round brings the company's total funding since its creation in mid-2019 to $2.1 million USD. This amount includes a previous investment from Techstars and Real Ventures via Techstars Montréal AI.
（以上内容由医药魔方AI生成）